Search clinical trials for: ALK Diluent

Total 256125 results

Matthew R Quigley
DUSA Pharmaceuticals, Inc.

Completed

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Glioblastoma

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Completed

Study of ACE-536 in Healthy Postmenopausal Women

Anemia

United States
Bispebjerg Hospital
ALK-Abelló A/S

Completed

Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen

Allergic Rhinitis Due to Grass Pollens

Denmark
Mural Oncology, Inc

Recruiting

Nemvaleukin Alfa (ALKS 4230) Monotherapy in Patients With Advanced Cutaneous Melanoma or Advanced Mucosal Melanoma - ARTISTRY-6 (ARTISTRY-6)

Cutaneous Melanoma | Mucosal Melanoma

United States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
David W. Roberts
National Institute of Neurological Disorders and Stroke (NINDS); Carl Zeiss...

Recruiting

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Brain Cancer

United States
Michael Vogelbaum, MD, PhD
National Cancer Institute (NCI)

Terminated

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain Tumor

United States
University of Hawaii
SBI ALApromo Co., Ltd. - Strategic Business Innovator

Completed

Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood

Stress | Insomnia | Irritability | Coping Behavior | Nocturnal Awakening

United States
University Hospital, Caen

Unknown

General Anesthesia Versus Locoregional Anesthesia for Evacuation of Chronic Subdural Hematoma

Chronic Subdural Hematoma

France
ALK-Abelló A/S

Completed

Tolerability of Grazax-R in Children

Allergy

Germany
ALK-Abelló A/S

Completed

Tolerability of ALK Grass Tablet in Children

Allergy

Spain
ALK-Abelló A/S

Completed

Safety of ALK Ragweed Tablet

Allergy

United States
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Asthma

Denmark
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
Shayan Moosa, MD

Recruiting

Sonodynamic Therapy in Patients With Recurrent GBM (GBM 001)

Glioblastoma Multiforme | GBM | Recurrent Glioblastoma

United States
Case Comprehensive Cancer Center

Recruiting

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Basal Cell Carcinoma

United States
LG Chem

Unknown

Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection
University Hospitals Cleveland Medical Center

Completed

Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana

Onchocerciasis

Ghana
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Completed

Walk With Ease Program For Patients With Systemic Lupus Erythematosus (Walk SLE)

Systemic Lupus Erythematosus

United States
Ablynx

Completed

ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers

Healthy | RSV Infection

Belgium
Mark Dignan, PhD

Completed

Faith-Based Initiative to Promote Health in Appalachia

Obesity | Cancer

United States
Shanghai East Hospital
Chinese Academy of Sciences

Unknown

Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure

Liver Failure, Acute
Blythedale Children's Hospital

Recruiting

Investigating the Use of the WalkAide on a Child's Ability to Ascend/Descend Stairs and Curbs

Cerebral Palsy

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

Basal Cell Carcinoma | Nodular Basal Cell Carcinoma | Superficial Basal Cell Carcinoma | BCC | BCC - Basal Cell Carcinoma | Basal Cell Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

Metastatic Breast Cancer

United States
Alios Biopharma Inc.

Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Moldova, Republic of, New Zealand, Thailand, Ukraine
The Medicines Company

Completed

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) (ORION-1)

Diabetes | Familial Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

Canada, Netherlands, United States, United Kingdom, Germany
Ablynx

Completed

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

United States, Hungary, Spain, Philippines, Poland, Serbia, Argentina, Chile, Czechia, Germany, Korea, Republic of, Mexico, Peru, Portugal, Russian Federation, Taiwan, Ukraine
Alnylam Pharmaceuticals

Terminated

A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B Infection

United Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong
Ablynx

Completed

ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers

RSV Infection

Netherlands
SOFAR S.p.A.

Completed

Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot Study

Uterine Diseases | Adnexal Diseases

Italy
Alleanza Pharmaceuticals, Inc.

Completed

Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

Primary Open Angle Glaucoma | Ocular Hypertension | Elevated Intraocular Pressure

United States
Alkermes, Inc.

Completed

ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD

Major Depressive Disorder

United States
University of Zurich

Unknown

Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)

Glioblastoma

Switzerland
Aligos Therapeutics

Recruiting

A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Chronic Hepatitis B

Hong Kong, China, United Kingdom, Moldova, Republic of, New Zealand, Australia, Mauritius
Mansoura University Children Hospital

Unknown

Influence of Bovine Lactoferrin on Feeding Intolerance and Intestinal Permeability in Preterm Neonates

Feeding Intolerance in Preterm | Intestinal Permeability in Preterm

Egypt
University of California, San Francisco

Terminated

Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain (ALA)

Glioma

United States
Ablynx

Completed

ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Respiratory Syncytial Virus Infection

Germany
Sun Yat-sen University

Suspended

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus
Alkermes, Inc.

Completed

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Opioid-induced Constipation

United States
Mireille Joussemet
Canadian Institutes of Health Research (CIHR)

Recruiting

Improving Preschoolers' Mental Health: A RCT Assessing Two Parenting Programs

Parenting | Mental Health Issue

Canada
Edward Nelson
National Cancer Institute (NCI); University of California, Irvine

Withdrawn

A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer

Colon Cancer

United States
New York University

Recruiting

Implementing Tobacco Use Treatment in HIV Clinics Vietnam (Vquit)

Tobacco Use

Vietnam
Washington University School of Medicine
Case Western Reserve University; University of Health and Allied Sciences

Completed

Safety and Efficacy of IDA for Onchocerciasis (DOLF IDA/Oncho)

Onchocerciasis

Ghana
Ablynx

Completed

Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection (Respire)

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Belgium, Hungary, Israel, Spain, Estonia, Philippines, Thailand, Bulgaria, Poland, Germany, Chile, Colombia, Croatia, Czechia, Latvia, Malaysia, Slovakia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Clinical Study for AL-CM

Immunoglobulin Light Amyloidosis Cardiomyopathy

China
National Institute of Allergy and Infectious Diseases...

Completed

A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes

HIV Infections

United States
Alios Biopharma Inc.

Completed

A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants

Hepatitis B

New Zealand
Takeda

Completed

A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors

Carcinoma Non-small-cell Lung | Anaplastic Lymphoma Kinase-positive

United States
Harbin Medical University

Completed

Therapeutic Effect of Crizotinib for Rearrangement-negative, High Phosphorylated ALK Patients

ALK Phosphorylation

China

Search clinical trials for: ALK Diluent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations